Modalis Therapeutics Corporation (TYO:4883)

Modalis Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,812	3,575	1,883	2,933	4,936
Cash & Short-Term Investments	2,812	3,575	1,883	2,933	4,936
Cash Growth	-21.33%	89.86%	-35.80%	-40.58%	-8.95%
Inventory	-	-	6	40	-
Other Current Assets	79.91	42	67	88	131
Total Current Assets	2,892	3,617	1,956	3,061	5,067
Property, Plant & Equipment	-	-	-	-	223
Long-Term Investments	71.98	74	69	68	73
Other Intangible Assets	-	-	-	-	705
Other Long-Term Assets	-	-	-	-	1
Total Assets	2,964	3,691	2,025	3,129	6,069
Accounts Payable	94.4	1	-	-	1
Accrued Expenses	25.75	20	91	17	25
Current Income Taxes Payable	13.33	95	105	123	126
Other Current Liabilities	1.32	1	2	1	28
Total Current Liabilities	134.8	117	198	141	180
Long-Term Debt	-	-	412	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	5
Other Long-Term Liabilities	36.14	28	36	49	335
Total Liabilities	170.95	145	646	190	520
Common Stock	1,728	1,758	1,217	2,094	2,744
Additional Paid-In Capital	3,050	3,080	2,539	3,416	4,066
Retained Earnings	-2,037	-1,325	-2,410	-2,605	-1,266
Treasury Stock	-0.1	-	-	-	-
Comprehensive Income & Other	52.72	33	33	34	5
Shareholders' Equity	2,793	3,546	1,379	2,939	5,549
Total Liabilities & Equity	2,964	3,691	2,025	3,129	6,069
Total Debt	-	-	412	-	-
Net Cash (Debt)	2,812	3,575	1,471	2,933	4,936
Net Cash Growth	-21.33%	143.03%	-49.85%	-40.58%	-8.95%
Net Cash Per Share	36.40	77.50	47.50	100.77	171.67
Filing Date Shares Outstanding	69.4	73.55	33.81	30.09	29.04
Total Common Shares Outstanding	69.4	69.4	33.36	29.36	28.97
Working Capital	2,757	3,500	1,758	2,920	4,887
Book Value Per Share	40.25	51.09	41.34	100.09	191.56
Tangible Book Value	2,793	3,546	1,379	2,939	4,844
Tangible Book Value Per Share	40.25	51.09	41.34	100.09	167.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.